Captrust Financial Advisors Biote Corp. Transaction History
Captrust Financial Advisors
- $38.8 Billion
- Q1 2025
A detailed history of Captrust Financial Advisors transactions in Biote Corp. stock. As of the latest transaction made, Captrust Financial Advisors holds 17,939 shares of BTMD stock, worth $51,664. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,939
Previous 18,613
3.62%
Holding current value
$51,664
Previous $116,000
49.14%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BTMD
# of Institutions
94Shares Held
16.5MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$13.1 Million7.37% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$6.58 Million4.11% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$4.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA685KShares$1.97 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $21.8M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...